Related Experiment Video
Updated: Sep 7, 2025
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Standardized Scoring Tool and Weaning Guideline to Reduce Opioids in Critically Ill Neonates
Dipen Vyas1,2, Vilmaris Quinones Cardona1,2, Amanda Carroll1,3
1Division of Neonatology, St. Christopher's Hospital for Children, Philadelphia, Pennsylvania.
Insights
Implementing standardized opioid weaning protocols significantly reduced opioid exposure in critically ill neonates. This quality improvement initiative decreased average opioid duration, enhancing neurodevelopmental outcomes for vulnerable infants.
Area of Science:
- Neonatal Intensive Care Unit (NICU) care
- Pediatric pharmacology
- Quality improvement science
Background:
- Neonatal pain and sedation often require prescription opioids, but prolonged exposure can impair neurodevelopment.
- A clinical paradox exists in balancing adequate pain management with minimizing opioid harm in neonates.
- Critically ill neonates face risks from both inadequate pain control and extended opioid use.
Purpose of the Study:
- To decrease the average duration of opioid use for analgesia or sedation in critically ill neonates by 10% within one year.
- To address the challenge of prolonged opioid exposure in a level IV Neonatal Intensive Care Unit (NICU).
Main Methods:
- A multidisciplinary quality improvement team employed the model for improvement methodology.
- A Pareto analysis identified inconsistent opioid weaning as a key driver of prolonged exposure.
- Interventions included a standardized withdrawal assessment tool and a risk-stratified opioid weaning guideline.
Main Results:
- Mean opioid duration decreased substantially from 34.3 to 14.1 days.
- Documentation of nursing withdrawal assessments increased from 20% to 90%.
- Provider documentation of the rationale for daily opioid doses rose from 20% to 70%.
Conclusions:
- Standardized withdrawal assessments are effective in reducing opioid use in neonates.
- Risk-stratified weaning guidelines, when combined with assessments, can decrease opioid exposure.
- This approach offers a viable solution to the clinical paradox of opioid use in critically ill neonates.
Introduction:
Pain impacts brain development for neonates, causing deleterious neurodevelopmental outcomes. Prescription opioids for analgesia or sedation are common; however, prolonged opioid exposure in neonates is associated with neurodevelopmental impairment. Balancing the impact of inadequate pain control against prolonged opioid exposure in neonates is a clinical paradox. Therefore, we sought to decrease the average days of opioids used for analgesia or sedation in critically ill neonates at a level IV Neonatal Intensive Care Unit by 10% within 1 year.
Methods:
A multidisciplinary quality improvement team used the model for improvement, beginning with a Pareto analysis, and identified a lack of consistent approach to weaning opioids as a primary driver for prolonged exposure. The team utilized 2 main interventions: (1) a standardized withdrawal assessment tool-1 and (2) a risk-stratified opioid weaning guideline.
Results:
We demonstrated a reduction in mean opioid duration from 34.3 to 14.1 days, an increase in nursing withdrawal assessment tool-1 documentation from 20% to 90%, and an increase in the documented rationale for daily opioid dose in provider notes from 20% to 70%. Benzodiazepine use did not change.
Conclusion:
Standardized withdrawal assessments combined with risk-stratified weaning guidelines can decrease opioid use in critically ill neonates.
More Related Videos
06:04Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
Published on: July 4, 2018
11:27A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
